[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Human Hepatitis B Immunoglobulin (IM) Market Report 2016

December 2016 | 114 pages | ID: U5AF1BF135BEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Human Hepatitis B Immunoglobulin (IM)

Revenue, means the sales value of Human Hepatitis B Immunoglobulin (IM)

This report studies sales (consumption) of Human Hepatitis B Immunoglobulin (IM) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Baxter
  • CSL
  • Bayer
  • Grifols
  • Octapharma
  • Shanghai RAAS
  • Hualan Biological
  • China Biologic
  • Tiantan Biologic
  • Shuanglin Bio-pharmacy
  • Sichuan Yuanda Shuyang
  • Boya Bio-pharmaceutical
  • Shanghai Institute of Biological
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • 100IU/Bottle Human Hepatitis B Immunoglobulin (IM)
  • 200IU/Bottle Human Hepatitis B Immunoglobulin (IM)
  • 400IU/Bottle Human Hepatitis B Immunoglobulin (IM)
Split by applications, this report focuses on sales, market share and growth rate of Human Hepatitis B Immunoglobulin (IM) in each application, can be divided into
  • Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
  • Unexpected Crowd of Hepatitis B Infection
  • Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
United States Human Hepatitis B Immunoglobulin (IM) Market Report 2016

1 HUMAN HEPATITIS B IMMUNOGLOBULIN (IM) OVERVIEW

1.1 Product Overview and Scope of Human Hepatitis B Immunoglobulin (IM)
1.2 Classification of Human Hepatitis B Immunoglobulin (IM)
  1.2.1 100IU/Bottle Human Hepatitis B Immunoglobulin (IM)
  1.2.2 200IU/Bottle Human Hepatitis B Immunoglobulin (IM)
  1.2.3 400IU/Bottle Human Hepatitis B Immunoglobulin (IM)
1.3 Application of Human Hepatitis B Immunoglobulin (IM)
  1.3.1 Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
  1.3.2 Unexpected Crowd of Hepatitis B Infection
  1.3.3 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Human Hepatitis B Immunoglobulin (IM) (2011-2021)
  1.4.1 United States Human Hepatitis B Immunoglobulin (IM) Sales and Growth Rate (2011-2021)
  1.4.2 United States Human Hepatitis B Immunoglobulin (IM) Revenue and Growth Rate (2011-2021)

2 UNITED STATES HUMAN HEPATITIS B IMMUNOGLOBULIN (IM) COMPETITION BY MANUFACTURERS

2.1 United States Human Hepatitis B Immunoglobulin (IM) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Human Hepatitis B Immunoglobulin (IM) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Human Hepatitis B Immunoglobulin (IM) Average Price by Manufactures (2015 and 2016)
2.4 Human Hepatitis B Immunoglobulin (IM) Market Competitive Situation and Trends
  2.4.1 Human Hepatitis B Immunoglobulin (IM) Market Concentration Rate
  2.4.2 Human Hepatitis B Immunoglobulin (IM) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HUMAN HEPATITIS B IMMUNOGLOBULIN (IM) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Human Hepatitis B Immunoglobulin (IM) Sales and Market Share by Type (2011-2016)
3.2 United States Human Hepatitis B Immunoglobulin (IM) Revenue and Market Share by Type (2011-2016)
3.3 United States Human Hepatitis B Immunoglobulin (IM) Price by Type (2011-2016)
3.4 United States Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate by Type (2011-2016)

4 UNITED STATES HUMAN HEPATITIS B IMMUNOGLOBULIN (IM) SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Human Hepatitis B Immunoglobulin (IM) Sales and Market Share by Application (2011-2016)
4.2 United States Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES HUMAN HEPATITIS B IMMUNOGLOBULIN (IM) MANUFACTURERS PROFILES/ANALYSIS

5.1 Baxter
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Baxter Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 CSL
  5.2.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 CSL Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bayer
  5.3.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bayer Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Grifols
  5.4.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Grifols Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Octapharma
  5.5.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Octapharma Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Shanghai RAAS
  5.6.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Hualan Biological
  5.7.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Hualan Biological Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 China Biologic
  5.8.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 China Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Tiantan Biologic
  5.9.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Shuanglin Bio-pharmacy
  5.10.2 Human Hepatitis B Immunoglobulin (IM) Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Sichuan Yuanda Shuyang
5.12 Boya Bio-pharmaceutical
5.13 Shanghai Institute of Biological

6 HUMAN HEPATITIS B IMMUNOGLOBULIN (IM) MANUFACTURING COST ANALYSIS

6.1 Human Hepatitis B Immunoglobulin (IM) Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin (IM)

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Human Hepatitis B Immunoglobulin (IM) Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Human Hepatitis B Immunoglobulin (IM) Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES HUMAN HEPATITIS B IMMUNOGLOBULIN (IM) MARKET FORECAST (2016-2021)

10.1 United States Human Hepatitis B Immunoglobulin (IM) Sales, Revenue Forecast (2016-2021)
10.2 United States Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Type (2016-2021)
10.3 United States Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Application (2016-2021)
10.4 Human Hepatitis B Immunoglobulin (IM) Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Human Hepatitis B Immunoglobulin (IM)
Table Classification of Human Hepatitis B Immunoglobulin (IM)
Figure United States Sales Market Share of Human Hepatitis B Immunoglobulin (IM) by Type in 2015
Figure 100IU/Bottle Human Hepatitis B Immunoglobulin (IM) Picture
Figure 200IU/Bottle Human Hepatitis B Immunoglobulin (IM) Picture
Figure 400IU/Bottle Human Hepatitis B Immunoglobulin (IM) Picture
Table Application of Human Hepatitis B Immunoglobulin (IM)
Figure United States Sales Market Share of Human Hepatitis B Immunoglobulin (IM) by Application in 2015
Figure Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg) Examples
Figure Unexpected Crowd of Hepatitis B Infection Examples
Figure Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers Examples
Figure United States Human Hepatitis B Immunoglobulin (IM) Sales and Growth Rate (2011-2021)
Figure United States Human Hepatitis B Immunoglobulin (IM) Revenue and Growth Rate (2011-2021)
Table United States Human Hepatitis B Immunoglobulin (IM) Sales of Key Manufacturers (2015 and 2016)
Table United States Human Hepatitis B Immunoglobulin (IM) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Hepatitis B Immunoglobulin (IM) Sales Share by Manufacturers
Figure 2016 Human Hepatitis B Immunoglobulin (IM) Sales Share by Manufacturers
Table United States Human Hepatitis B Immunoglobulin (IM) Revenue by Manufacturers (2015 and 2016)
Table United States Human Hepatitis B Immunoglobulin (IM) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Human Hepatitis B Immunoglobulin (IM) Revenue Share by Manufacturers
Table 2016 United States Human Hepatitis B Immunoglobulin (IM) Revenue Share by Manufacturers
Table United States Market Human Hepatitis B Immunoglobulin (IM) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Human Hepatitis B Immunoglobulin (IM) Average Price of Key Manufacturers in 2015
Figure Human Hepatitis B Immunoglobulin (IM) Market Share of Top 3 Manufacturers
Figure Human Hepatitis B Immunoglobulin (IM) Market Share of Top 5 Manufacturers
Table United States Human Hepatitis B Immunoglobulin (IM) Sales by Type (2011-2016)
Table United States Human Hepatitis B Immunoglobulin (IM) Sales Share by Type (2011-2016)
Figure United States Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type in 2015
Table United States Human Hepatitis B Immunoglobulin (IM) Revenue and Market Share by Type (2011-2016)
Table United States Human Hepatitis B Immunoglobulin (IM) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Hepatitis B Immunoglobulin (IM) by Type (2011-2016)
Table United States Human Hepatitis B Immunoglobulin (IM) Price by Type (2011-2016)
Figure United States Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate by Type (2011-2016)
Table United States Human Hepatitis B Immunoglobulin (IM) Sales by Application (2011-2016)
Table United States Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2011-2016)
Figure United States Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application in 2015
Table United States Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate by Application (2011-2016)
Figure United States Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate by Application (2011-2016)
Table Baxter Basic Information List
Table Baxter Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table CSL Basic Information List
Table CSL Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Grifols Basic Information List
Table Grifols Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Octapharma Basic Information List
Table Octapharma Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Shanghai RAAS Basic Information List
Table Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Hualan Biological Basic Information List
Table Hualan Biological Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Biological Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table China Biologic Basic Information List
Table China Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table China Biologic Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Tiantan Biologic Basic Information List
Table Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Shuanglin Bio-pharmacy Basic Information List
Table Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Sichuan Yuanda Shuyang Basic Information List
Table Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Boya Bio-pharmaceutical Basic Information List
Table Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Shanghai Institute of Biological Basic Information List
Table Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Hepatitis B Immunoglobulin (IM)
Figure Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin (IM)
Figure Human Hepatitis B Immunoglobulin (IM) Industrial Chain Analysis
Table Raw Materials Sources of Human Hepatitis B Immunoglobulin (IM) Major Manufacturers in 2015
Table Major Buyers of Human Hepatitis B Immunoglobulin (IM)
Table Distributors/Traders List
Figure United States Human Hepatitis B Immunoglobulin (IM) Production and Growth Rate Forecast (2016-2021)
Figure United States Human Hepatitis B Immunoglobulin (IM) Revenue and Growth Rate Forecast (2016-2021)
Table United States Human Hepatitis B Immunoglobulin (IM) Production Forecast by Type (2016-2021)
Table United States Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories